2-Oxazolidinone → HCID 67447065, compound

HRID 1804168Notes

Reaction equation

HRID 1804168 reaction equation
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[CH:21]=[CH:20][C:19]([Cl:22])=[CH:18][C:17]=3[Cl:23])[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1.[O:24]1[CH2:28][CH2:27][NH:26][C:25]1=[O:29]>>[Cl:23][C:17]1[CH:18]=[C:19]([Cl:22])[CH:20]=[CH:21][C:16]=1[N:13]1[CH2:14][CH2:15][N:10]([C:8]([C:5]2[CH:6]=[CH:7][C:2]([N:26]3[CH2:27][CH2:28][O:24][C:25]3=[O:29])=[CH:3][CH:4]=2)=[O:9])[CH2:11][CH2:12]1

Participants

3

Reactant 2

HCID 739492-OxazolidinoneHCID 58484869(4-Bromophenyl)[4-(2,4-dichlorophenyl)piperazin-1-yl]methanone

Product 1

HCID 67447065HCID 67447065, compoundYield 58.6%

Procedure

By reaction and treatment in the same manner as in Example 1 and using (4-bromophenyl)[4-(2,4-dichlorophenyl)piperazin-1-yl]methanone (828 mg) described in Preparation Example 19 and oxazolidin-2-one (174 mg), the title compound (492 mg) was obtained.

Workup

  1. customBy reaction and treatment in the same manner as in Example 1

Sources & evidence

ORD record
ord-15eff961afdc4819bfc1686d446ea7c5
Source dataset
uspto-grants-2013_01
Patent number
US08354401B2

Reaction notes

Loading…